![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Sarcoma, Ewing - 20 Studies Found
Recruiting |
: TK216 in Patients With Relapsed or Refractory Ewing Sarcoma : Sarcoma, Ewing : 2016-01-12 : Drug: TK216 Inhibitor of protein-protein interactions of EWS-FLI1 fusion protein |
Completed |
: Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment : Sarcoma, Ewing's : 2009-01-15 |
Withdrawn |
: A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma : Ewing Sarcoma : 2013-10-21 :
|
Recruiting |
: Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma : Ewing's Sarcoma : 2013-02-21 :
|
Recruiting |
: A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma : Ewing's Sarcoma : 2015-07-28 :
|
Completed |
: Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma : Non-Metastatic Ewings Sarcoma : 2006-06-19 |
Active, not recruiting |
: Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults : Ewing's Sarcoma : 2011-06-30 :
|
Recruiting |
: Study in Localized and Disseminated Ewing Sarcoma : Ewing's Sarcoma : 2009-09-30 :
|
Terminated |
: Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) : Ewing's Sarcoma : 2007-12-05 : Drug: VCR, CTX, ADM; IFO, VP-16 VCD: VCR 2 mg d1, CTX 1200 mg/m2 d1, Mesna 240 mg/m2 tid d1, ADM 75mg/m2 |
Completed |
: Aerosol L9-NC and Temozolomide in Ewing's Sarcoma : Ewing's Sarcoma : 2007-06-26 :
|